BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4105883)

  • 1. Delay of the heterograft reaction by selective plasmapharesis.
    Merkel FK; Bier M; Beavers CD; Merriman WG; Starzl TE
    Surg Forum; 1970; 21():261-3. PubMed ID: 4105883
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of heterograft survival by electrophoretic extraction of preformed antibody.
    Shons AR; Jetzer T; Moberg AW; Najarian JS
    Surg Forum; 1970; 21():263-5. PubMed ID: 4105884
    [No Abstract]   [Full Text] [Related]  

  • 3. Delay of xenograft rejection through oxidation of blood during hemodialysis.
    Bier M; Zukoski F; Boyer JT; Beavers CD; Merriman WG
    Trans Am Soc Artif Intern Organs; 1971; 17():64-74. PubMed ID: 4945714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental xenografting in widely divergent species. Modification of the hyperacute xenogeneic rejection of kidneys from pigs (donor) by extreme hemodilution of dogs (recipients) (author's transl)].
    Fiedler L; Hammer C; Messmer K; Land W; Holper K; Klövekorn W; Pielsticker K; Chaussy C; Brendel W
    Res Exp Med (Berl); 1974 Jun; 163(2):137-53. PubMed ID: 4136361
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of renal xenografts by the simultaneous sequestration of preformed antibody, inhibition of complement, coagulation and antibody synthesis.
    Moberg AW; Shons AR; Gewurz H; Mozes M; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):538-41. PubMed ID: 4937935
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged survival of kidney xenografts in leucopenic rabbits.
    Mejía-Laguna JE; Martínez-Palomo A; López-Soriano F; García-Cornjeo M; Biro CE
    Immunology; 1971 Dec; 21(6):879-82. PubMed ID: 4943145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of human renal disease by immunofluorescent methods.
    Hadley WK; Rosenau W
    Arch Pathol; 1967 Apr; 83(4):342-51. PubMed ID: 4164544
    [No Abstract]   [Full Text] [Related]  

  • 8. Xenograft rejection by dog and man: isolated kidney perfusion with blood and plasma.
    Mozes MF; Gewurz H; Gunnarson A; Moberg AW; Westberg NG; Jetzer T; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):531-3. PubMed ID: 4937933
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of leukocytes and lysosomal enzymes in antibody-mediated (hyperacute) rejection of renal heterografts.
    Palutke M; Kihn R; Perry M; Riddle J; Rector F; Rosenberg JC
    Lab Invest; 1972 Sep; 27(3):287-95. PubMed ID: 4341548
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective plasmapheresis in dogs for delay of heterograft response.
    Bier M; Beavers CD; Merriman WG; Merkel FK; Eiseman B; Starzl TZ
    Trans Am Soc Artif Intern Organs; 1970; 16():325-33. PubMed ID: 4916739
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the mechanism of canine renal allograft rejection.
    Foker JE; Clark DS; Pickering RJ; Good RA; Varco RL
    Transplant Proc; 1969 Mar; 1(1):296-300. PubMed ID: 4944231
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro studies on the mechanism of hyperacute xenograft rejection.
    Land W; Schilling A; Aldenhoff J; Lamerz R; Pielsticker K; Mendler N; Brendel W
    Transplant Proc; 1971 Mar; 3(1):888-90. PubMed ID: 4937986
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of xenograft response by selective plasmapheresis.
    Merkel FK; Bier M; Beavers CD; Merriman WG; Wilson C; Starzl TE
    Transplant Proc; 1971 Mar; 3(1):534-7. PubMed ID: 4937934
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate.
    Kux M; Boehmig HJ; Amemiya H; Torisu M; Yokoyama T; Launois B; Popovtzer M; Wilson CB; Dixon FJ; Starzl TE
    Surgery; 1971 Jul; 70(1):103-12. PubMed ID: 4933439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperacute rejection in heterotopic transplantation of the liver].
    Machado MC; Bacchella T; da Cunha JE; Gonçales Y; de Campos FF; Jukemura J
    Rev Hosp Clin Fac Med Sao Paulo; 1982 Jun; 37(3):128-35. PubMed ID: 6755624
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of the heteroantibody in xenograft rejection.
    Mozes MF; Shons AR; Harris NS; Merino GE; Moberg AW; Campos RA; Najarian JS
    Surg Forum; 1971; 22():244-6. PubMed ID: 4941308
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of hyperactue xenogeneic kidney rejection.
    Messmer K; Hammer C; Land W; Fiedler L; Klövekorn WP; Holper K; Lob G; Merzel D; Brendel W
    Transplant Proc; 1971 Mar; 3(1):542-4. PubMed ID: 4937936
    [No Abstract]   [Full Text] [Related]  

  • 18. Discordant liver xenograft transplantation.
    Ohta K; Tanaka N; Orita K
    Transplant Proc; 1994 Aug; 26(4):2435-8. PubMed ID: 8066799
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolongation of renal xenografts by complement suppression.
    Snyder GB; Ballesteros E; Zarco RM; Linn BS
    Surg Forum; 1966; 17():478-80. PubMed ID: 5331830
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum complement in the rejection of sarcoma I ascites tumor grafts.
    Phillips ME; Rother U; Rother K
    J Immunol; 1968 Mar; 100(3):493-500. PubMed ID: 4171118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.